• Current Updates in the Triple Therapy for Asthma

• Lee Chang-Hoon

• 企尖己企龙券   2021  Volume.9  No.2 90 ~ 93

• Ra Seung-Won

• 企尖己企龙券   2021  Volume.9  No.2 85 ~ 89

• Ko Eun-Jae

• Ra Seung-Won

• 企尖己企龙券   2021  Volume.9  No.2 80 ~ 84

• The Role of Lung and Diaphragm Ultrasound in Pulmonary Rehabilitation

• An Tai-Joon

• 企尖己企龙券   2021  Volume.9  No.2 73 ~ 79

• Biomarker of COPD

• Koo Hyeon-Kyoung

• 企尖己企龙券   2021  Volume.9  No.2 69 ~ 72

• COPD and Cardiovascular Disease

• Jung Ji-Ye

• 企尖己企龙券   2021  Volume.9  No.2 64 ~ 68

• Scientific Update of Singulair - Focused on Neuropsychiatric Disorder

• Park Hye-Jung

• 企尖己企龙券   2021  Volume.9  No.2 59 ~ 63

• Lee Sei-Won

• 企尖己企龙券   2021  Volume.9  No.2 53 ~ 58

• Current Practice of COPD Combined with ILD - View from COPD Expert

• Rhee Chin-Kook

• 企尖己企龙券   2021  Volume.9  No.2 49 ~ 52

• Lung Organoids: Current Approaches and Future Promise

• Kim Jung-Hyun

• Hong Seok-Ho

• 企尖己企龙券   2021  Volume.9  No.1 44 ~ 47

• Chronic Obstructive Pulmonary Disease and Lung Cancer in Never Smokers

• Lee Hyun, Park Hye-Yun

• 企尖己企龙券   2021  Volume.9  No.1 42 ~ 43

• When Is Dual Bronchodilator Therapy Indicated as Initial Treatment?

• Kang Ji-Eun

• 企尖己企龙券   2021  Volume.9  No.1 37 ~ 41

• Stable Clinical Course of COPD with LAMA/LABA

• Kang No-Eul

• Shin Sun-Hye, Park Hye-Yun

• 企尖己企龙券   2021  Volume.9  No.1 33 ~ 36

• ICS Usage in Real Practice and Appropriate Treatment

• Moon Ji-Yong

• 企尖己企龙券   2021  Volume.9  No.1 25 ~ 32

• Korean COPD Guideline

• Jung Ji-Ye

• 企尖己企龙券   2021  Volume.9  No.1 21 ~ 24

• Characteristics of Korean COPD Patients

• Rhee Chin-Kook

• 企尖己企龙券   2021  Volume.9  No.1 16 ~ 20

• Lee Ye-Jin

• Park Yong-Bum

• 企尖己企龙券   2021  Volume.9  No.1 11 ~ 15

• Ra Seung-Won

• 企尖己企龙券   2021  Volume.9  No.1 6 ~ 10

• Kim Hyun-Jung

• 企尖己企龙券   2021  Volume.9  No.1 1 ~ 5